Close Sidebar
Nordic Life Science
Now Reading
AstraZeneca completes Japanese acquisition
Search for content, post, videos
Search for content, post, videos
Advertisement

AstraZeneca completes Japanese acquisition

March 26, 2014
3302 Views
Marc-Dunoyer

AstraZeneca completes purchase of Sumitomo Chemical’s stake in AstraZeneca K.K.

The company announced on March 26 that it has completed the purchase of Sumitomo Chemical’s remaining shares in AstraZeneca K.K. According to a statement the purchase was valued at approximately JPY10 billion ($102 million). This gives AstraZeneca control of the entire shareholding of AstraZeneca K.K.

“Our decision to gain full control of AstraZeneca K.K. reinforces our focus on Japan as a key growth platform,” commented Marc Dunoyer, Chief Financial Officer, AstraZeneca, in a press release.

Advertisement
Advertisement

Related Posts

signing-agreement
April 11, 2016

CareDx’s offer to the shareholders of Swedish Allenex has been accepted by shareholders holding an aggregate of 118,207,862 shares, corresponding to approximately 98.3% of the total number of shares in Allenex. CareDx declares the offer unconditional and completes the offer.  The settlement is expected to occur on or around April…

April 22, 2015

Attorney Stefan Wendén, a managing partner in a Swedish law firm, is now part of the Malmö-based research park Medeons first virtual management team. The new concept is being tested at Richter Life Science Development, founded by Agneta Richter Dahlfors, professor of microbiology at Karolinska Institutet, according to Swedish Life…

Guido Oelkers
September 6, 2021

Investor AB has undertaken to accept the public offer made September 2, by Agnafit Bidco for the shares in Swedish Orphan Biovitrum at a price per share of SEK 235. Investor owns 107.6 million shares in Sobi, representing 35.4 percent of the capital and votes. The offer values Investor’s shares…

agreement
April 9, 2015

The sale of the rights to Karolinska Institutet Innovations AB project Extroducer to the company Smart Wise AB is KI Innovations second major deal in fewer than six months. The device is a microcatheter with unique features that make it possible to deliver drugs directly to hard- to-reach organs. The microcatheter was…